No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AYTU Aytu BioPharma
- 2.7800
- +0.0265+0.96%
Trading Jul 23 11:53 ET
16.60MMarket Cap-1139P/E (TTM)
2.7900High2.7500Low2.70KVolume2.7800Open2.7535Pre Close7.51KTurnover0.06%Turnover RatioLossP/E (Static)5.97MShares3.500052wk High0.54P/B11.68MFloat Cap1.520052wk Low--Dividend TTM4.20MShs Float27279.9864Historical High--Div YieldTTM1.45%Amplitude1.3800Historical Low2.7810Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Maxim Group Maintains Aytu BioPharma(AYTU.US) With Buy Rating, Maintains Target Price $8
It's Unlikely That The CEO Of Aytu BioPharma, Inc. (NASDAQ:AYTU) Will See A Huge Pay Rise This Year
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Q3 2024 Aytu Biopharma Inc Earnings Call
Aytu BioPharma | 10-Q: Quarterly report
Comments
$BioLine Rx(BLRX.US$ Very good news, money will be flowing in!! FDA approved drug getting dispersed world wide. $T2 Biosystems(TTOO.US$ $Aytu BioPharma(AYTU.US$ $
1
3
$Aytu BioPharma(AYTU.US$ beat earnings
4
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
heng heng888 : fda approve but why red. should be green..
71707398OP : hedgies playing games
TraderGuy : Got great news and has been tanking ever since. This is silly